Objectives-To assess urinary and synovial concentrations of hydroxypyridinium crosslinks of collagen in patients with rheumatoid arthritis (RA) and osteoarthritis (OA) and to evaluate whether a combined measurement in the two compartments could give additional information about the origin of these compounds in joint diseases. Methods-Concentrations of hydroxypyridinoline (HP) and lysylpyridinoline (LP) were measured by high pressure liquid chromatography in urinary and synovial samples collected from 20 patients with RA and 20 patients with knee OA. Full laboratory and clinical assessments were performed. Results-Urinary concentrations of both HP and LP were significantly greater in RA than in OA. Urinary HP in RA correlated with the number of swollen joints corrected for Lansbury index and with erythrocyte sedimentation rate and C reactive protein. In synovial fluid from both groups, only relatively small amounts of HP were measured, while bone type I collagen specific LP was below the limit of detection in all samples. In RA patients, but not in OA patients, there was a strong correlation between urinary and synovial concentrations of HP (r = 0.75).
Abstract
Objectives-To assess urinary and synovial concentrations of hydroxypyridinium crosslinks of collagen in patients with rheumatoid arthritis (RA) and osteoarthritis (OA) and to evaluate whether a combined measurement in the two compartments could give additional information about the origin of these compounds in joint diseases. Methods-Concentrations of hydroxypyridinoline (HP) and lysylpyridinoline (LP) were measured by high pressure liquid chromatography in urinary and synovial samples collected from 20 patients with RA and 20 patients with knee OA. Full laboratory and clinical assessments were performed. Results-Urinary concentrations of both HP and LP were significantly greater in RA than in OA. Urinary HP in RA correlated with the number of swollen joints corrected for Lansbury index and with erythrocyte sedimentation rate and C reactive protein. In synovial fluid from both groups, only relatively small amounts of HP were measured, while bone type I collagen specific LP was below the limit of detection in all samples. In RA patients, but not in OA patients, there was a strong correlation between urinary and synovial concentrations of HP (r = 0.75). In the synovial fluid of both RA and OA patients, relatively large amounts of HP were measured (RA mean 25-3 (SD 13-5) pmol/ml; OA mean 23-2 (8&4) pmol/ml), whereas the concentrations on type I collagen specific LP were below the limit of detection (< 1 pmollml) in all samples from both groups. We found a strong correlation between urinary and synovial concentrations of HP (r=0-75; p<0-0001) (fig 2) in RA patients but not in OA patients. In steroid treated RA patients, synovial concentrations of HP were significantly smaller than in subjects who were not receiving steroids (mean 16 1 (SD 7-7) pmol/ml v 28-7 (12-9) pmol/ml, respectively; p = 003). No correlation between synovial concentrations of HP and white cell count in synovial fluid was detected in either group.
Discussion
Our data confirm preliminary results showing that the rate of urinary excretion of pyridinium crosslinks is increased in patients with joint diseases. In each group studied, greater concentrations were found than in the control group of Seibel et a15 which included subjects to define the origin of crosslinks in joint diseases and to evaluate correlations with different stages of joint damage. Further prospective studies are also necessary to establish whether urinary or synovial pyridinolines alter in response to drug therapy, thus providing information for monitoring the progression of joint diseases.
